Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

15°
- Kane, PA (16735)
  Today
  
  Partly cloudy skies this evening. A few snow showers developing late. Low 13F. Winds SSW at 5 to 10 mph. Chance of snow 30%..
  
  Tonight
  
  Partly cloudy skies this evening. A few snow showers developing late. Low 13F. Winds SSW at 5 to 10 mph. Chance of snow 30%.
  
  Updated: December 12, 2025 @ 10:21 pm
- Full Forecast

Site search

Home
News
Sports
Obituaries
Local Events
- Promote Your Event
Photos
e-Edition
Classifieds
- Place an ad
Archives

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

89.83 -0.46 (-0.51%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AstraZeneca PLC - American Depositary Shares

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

59 60 Next >

Large Cap Biopharmaceuticals: Core Holdings For Your Portfolio ↗

October 03, 2022

Now that some clarity is apparent for drug pricing legislation you should have a few large-cap biopharmaceutical stocks in your portfolio.

Via Talk Markets

Will Chart Analysts Notice Bad Omen on AstraZeneca's Chart ↗

October 03, 2022

If history is any guide, there may be trouble ahead for shares of AstraZeneca (NASDAQ:AZN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the...

Via Benzinga

Why Is LogicBio (LOGC) Stock Up 600% Today? ↗

October 03, 2022

LogicBio (LOGC) stock is seeing massive gains on Monday following news that AstraZeneca (AZN) subsidiary Alexion is acquiring the company.

Via InvestorPlace

Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis ↗

October 03, 2022

Vaccines that boost the body’s immune system against foreign proteins are different than those that are an inverse vaccine fighting an autoimmune disease.

Via Benzinga

Why LogicBio Therapeutics Stock Is Soaring Today ↗

October 03, 2022

LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher Monday after the company announced it will be acquired by AstraZeneca PLC (NASDAQ: AZN) subsidiary Alexion for $2.07 per share.

Via Benzinga

PhaseBio Might Have To Return Global Rights To Its Lead Program ↗

September 28, 2022

Via Benzinga

Japan Approves AstraZeneca's Two Treatments For Asthma, Rare Form Of Cancer ↗

September 27, 2022

Via Benzinga

AstraZeneca's Asthma Treatment Scores European Approval ↗

September 21, 2022

Via Benzinga

Why Are LogicBio Therapeutics Shares Skyrocketing Today? ↗

October 03, 2022

Via Benzinga

AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know ↗

October 02, 2022

Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the...

Via Benzinga

7 Large-Cap Stocks With Sustained Dividend Growth Potential ↗

September 28, 2022

Large-cap stocks with dividend growth potential have robust cash flows and are likely to increase their dividends in the coming years.

Via InvestorPlace

7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’ ↗

September 27, 2022

Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over.

Via InvestorPlace

AstraZeneca's COVID-19 Antibody Treatment Scores Approval In Europe ↗

September 20, 2022

Via Benzinga

US Stock Futures Rise Ahead Of Economic Reports, Fed Speakers; Crude Oil Rises 1% ↗

September 27, 2022

Pre-open movers U.S. stock futures traded higher in early pre-market trade on Tuesday after recording losses on Monday. The Dow Jones fell into a bear market on Monday, while the S&P 500 recorded a...

Via Benzinga

Burberry Finance Chief Joins GSK As First Woman CFO ↗

September 26, 2022

Via Benzinga

European Stocks Are Left In Shambles From Russia-Ukraine War: It May Be Time To Buy These 2 High Yielders ↗

September 25, 2022

As the SPDR Portfolio Europe ETF (ARCA: SPEU) is down roughly 32% year-to-date, it may be a prime moment to hunt for stocks that have become undervalued in the European stock market. The SPDR Portfolio...

Via Benzinga

3 Medical Stocks Displaying Remarkable Relative Strength In 2022 ↗

September 24, 2022

3 medical stocks that displayed a substantial amount of relative strength year-to-date.

Via Talk Markets

Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test ↗

September 23, 2022

Though successful in early testing, it wasn't enough to win a Phase 3 study.

Via Investor's Business Daily

AstraZeneca Pulls Plug On Ionis Pharma-Partnered Cholesterol Med ↗

September 23, 2022

Via Benzinga

With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma ↗

September 21, 2022

Via Benzinga

AstraZeneca's COVID-19 Antibody Cocktail, RSV Treatment For Infants Gets European Authority Backing ↗

September 16, 2022

Via Benzinga

AstraZeneca's Blood Clot Treatment Hits Primary Goal In Rare Blood Disorder Trial ↗

September 16, 2022

Via Benzinga

Top Financial Stories Tuesday, September 13: Elon Musk's Takeover Set To Get Twitter Shareholder Approval, Intel Slashes Mobileye IPO Valuation, Goldman Sachs To Layoff About 500 Jobs And More... ↗

September 13, 2022

Wall Street Journal

Via Benzinga

US Judge Dismisses Shareholder Lawsuit Over AstraZeneca's COVID-19 Vaccine Disclosures: Report ↗

September 13, 2022

Via Benzinga

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary ↗

September 09, 2022

Via Benzinga

AstraZeneca-Merck's Lynparza Treatment Shows Long-Term Survival In Ovarian Cancer ↗

September 09, 2022

Via Benzinga

Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report ↗

September 06, 2022

Via Benzinga

AstraZeneca Imfinzi Combo Scores FDA Approval As First Immunotherapy Regimen For Biliary Tract Cancer ↗

September 06, 2022

Via Benzinga

White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗

September 02, 2022

Via Benzinga

Here's How Much $1000 Invested In AstraZeneca 5 Years Ago Would Be Worth Today ↗

September 01, 2022

AstraZeneca (NASDAQ:AZN) has outperformed the market over the past 5 years by 5.5% on an annualized basis producing an average annual return of 15.24%. Currently, AstraZeneca has a market...

Via Benzinga

< Previous 1 2

...

30 31 32 33 34 35 36 37 38

...

59 60 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

The Kane Republican

KaneRepublican.com
200 North Fraley
Kane, PA 16735
Phone: 814-837-6000
Email: krnews1@zitomedia.net

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Kane, PA (16735)

Today

Tonight

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

Headline News about AstraZeneca PLC - American Depositary Shares

Sections

Services

The Kane Republican